HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Juan A Rey Selected Research

Caspase 8 (Caspase-8)

2/2006Promoter CpG methylation of multiple genes in pituitary adenomas: frequent involvement of caspase-8.
11/2004DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q.
9/2004Deletion and aberrant CpG island methylation of Caspase 8 gene in medulloblastoma.
3/2004Aberrant CpG island methylation of multiple genes in ependymal tumors.
11/2003CpG island methylation in sporadic and neurofibromatis type 2-associated schwannomas.
9/2003Aberrant CpG island methylation in neurofibromas and neurofibrosarcomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Juan A Rey Research Topics

Disease

35Neoplasms (Cancer)
05/2021 - 03/2003
9Meningioma (Meningiomas)
06/2015 - 01/2004
9Glioma (Gliomas)
04/2015 - 01/2006
8Glioblastoma (Glioblastoma Multiforme)
05/2021 - 03/2003
7Brain Neoplasms (Brain Tumor)
05/2021 - 07/2003
7Medulloblastoma
09/2016 - 05/2003
6Astrocytoma (Pilocytic Astrocytoma)
02/2014 - 03/2003
6Oligodendroglioma
08/2013 - 07/2003
6Acoustic Neuroma (Acoustic Neurinoma)
03/2013 - 10/2007
4Neoplasm Metastasis (Metastasis)
01/2018 - 07/2003
4Carcinogenesis
07/2013 - 03/2003
4Neurilemmoma (Schwannoma)
03/2013 - 11/2003
3Neuroblastoma
01/2014 - 11/2010
2Stomach Neoplasms (Stomach Cancer)
10/2019 - 01/2018
2Carcinoma (Carcinomatosis)
03/2016 - 07/2003
2Primitive Neuroectodermal Tumors (PNET)
06/2011 - 10/2010
2Ependymoma
03/2004 - 07/2003
1Major Depressive Disorder (Major Depressive Disorders)
01/2022
1Infections
01/2018
1Spontaneous Remission
01/2014
1Ewing Sarcoma (Sarcoma, Ewing)
06/2011
1Nervous System Neoplasms (Neoplasms, Nervous System)
04/2010
1Deafness (Deaf Mutism)
10/2007
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2007
1Pituitary Neoplasms (Pituitary Adenoma)
02/2006
1Prolactinoma (Prolactinomas)
02/2006
1Adenoma (Adenomas)
02/2006
1Adenocarcinoma
10/2005

Drug/Important Bio-Agent (IBA)

10Tumor Suppressor Protein p14ARF (p14ARF)IBA
01/2012 - 03/2003
7Proteins (Proteins, Gene)FDA Link
04/2015 - 10/2005
6Caspase 8 (Caspase-8)IBA
02/2006 - 09/2003
5Temozolomide (Temodar)FDA LinkGeneric
01/2021 - 06/2013
5DNA (Deoxyribonucleic Acid)IBA
03/2016 - 07/2003
5Cyclin-Dependent Kinase Inhibitor p16IBA
01/2012 - 04/2003
5Tissue Inhibitor of Metalloproteinase-3IBA
11/2004 - 03/2003
3Cyclin D1IBA
01/2011 - 10/2007
3Complementary DNA (cDNA)IBA
01/2010 - 02/2009
3Death-Associated Protein KinasesIBA
01/2004 - 04/2003
2PanobinostatIBA
01/2021 - 01/2020
2RNA (Ribonucleic Acid)IBA
10/2019 - 01/2010
2Small Interfering RNA (siRNA)IBA
01/2018 - 11/2010
2Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
03/2015 - 08/2013
2lomeguatribIBA
02/2014 - 06/2013
2Neurofibromin 2 (Merlin)IBA
03/2013 - 10/2005
2Cyclin D2IBA
02/2011 - 11/2010
2gamma Catenin (Plakoglobin)IBA
02/2011 - 11/2010
2Epidermal Growth Factor (EGF)IBA
04/2010 - 10/2009
2Glutathione Transferase (Glutathione S-Transferase)IBA
01/2004 - 04/2003
1Biomarkers (Surrogate Marker)IBA
01/2022
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2022
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2022
1Cadherins (E-Cadherin)IBA
05/2021
1Protein Isoforms (Isoforms)IBA
05/2021
1Histone Deacetylase 6IBA
05/2021
1eprenetapoptIBA
01/2021
1Histone Deacetylase InhibitorsIBA
01/2020
1Histones (Histone)IBA
05/2019
1EnzymesIBA
05/2019
1UbiquitinIBA
01/2018
1Peptides (Polypeptides)IBA
10/2016
1Transforming Growth Factor beta (TGF-beta)IBA
10/2016
1SuspensionsIBA
09/2016
1Laminin (Merosin)IBA
09/2016
1X-linked Nuclear ProteinIBA
03/2015
1Culture MediaIBA
01/2014
12-toluenesulfonamide (OTS)IBA
08/2013
1Neurofibromin 1 (Neurofibromin)IBA
07/2013
1Caveolin 1IBA
03/2013
1Neuregulin-1 (Neuregulin 1)IBA
03/2013
1OsteopontinIBA
03/2013
1Androgen Receptors (Androgen Receptor)IBA
03/2013
1Messenger RNA (mRNA)IBA
03/2013
1IntegrinsIBA
03/2013
1MicroRNAs (MicroRNA)IBA
01/2013
1arginylarginine (Arg-Arg)IBA
10/2012
1arginylprolineIBA
10/2012
1prolyl-proline (Pro-Pro)IBA
10/2012
1Transforming Growth Factors (Transforming Growth Factor)IBA
10/2012
1Stem Cell FactorIBA
06/2011
1Imatinib Mesylate (Gleevec)FDA Link
06/2011
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2011
1Patched-1 ReceptorIBA
02/2011
1WD repeat containing planar cell polarity effectorIBA
02/2011
1CateninsIBA
02/2011
1Zinc Finger Protein GLI1IBA
02/2011
1CarcinogensIBA
01/2011
1cyclopamineIBA
10/2010
1Complement System Proteins (Complement)IBA
04/2009
1CyclinsIBA
10/2007
1ErbB Receptors (EGF Receptor)IBA
02/2007
1Gefitinib (Iressa)FDA Link
02/2007
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
02/2006
1Growth Hormone (Somatotropin)IBA
02/2006
1ezrinIBA
10/2005
1moesinIBA
10/2005

Therapy/Procedure

7Therapeutics
05/2021 - 11/2010
6Drug Therapy (Chemotherapy)
01/2021 - 04/2009
5Ligation
01/2014 - 01/2007
2Aftercare (After-Treatment)
01/2022 - 10/2010
2Radiotherapy
01/2021 - 01/2020